Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Bae Kim

Showing results (81-90 of 509) with videos related to

Pageof 51
Sort By:
Journal of Breast Cancer|January 16, 2016
Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative IISung-Bae Kim, Yau Tsz Kok, Tran Van Thuan, et al.
Human Pathology|August 30, 2006
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypesMi-Jung Kim, Jae Y Ro, Sei-Hyun Ahn, et al.
The Laryngoscope|February 19, 2013
Clinical characteristics and prognostic factors of adenoid cystic carcinoma of the head and neckYunsuk Choi, Sung-Bae Kim, Dok Hyun Yoon, et al.
Cancer Research and Treatment|June 27, 2021
Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerHyehyun Jeong, Jae Ho Jeong, Jeong Eun Kim, et al.
Future Oncology (London, England)|August 22, 2019
Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from AsiaBinghe Xu, Sung-Bae Kim, Kenichi Inoue, et al.
Cancer Research and Treatment|March 30, 2021
Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA TrialKyung-Hun Lee, Joohyuk Sohn, Annabel Goodwin, et al.
Journal of Korean Medical Science|June 18, 2004
Alternative therapy and abnormal liver function during adjuvant chemotherapy in breast cancer patientsJin-Hee Ahn, Sung-Bae Kim, Mi Ra Yun, et al.
The Laryngoscope|June 1, 2017
Pretreatment albumin level predicts survival in head and neck squamous cell carcinomaWon Sub Lim, Jong-Lyel Roh, Sung-Bae Kim, et al.
International Journal of Clinical Oncology|July 21, 2017
Aspirin use and head and neck cancer survival: an observational study of 11,623 person-years follow-upShin-Ae Kim, Jong-Lyel Roh, Sung-Bae Kim, et al.
Medicine|May 14, 2016
Noncancer-Related Health Events and Mortality in Head and Neck Cancer Patients After Definitive Radiotherapy: A Prospective StudyHo-Seob Kang, Jong-Lyel Roh, Sung-Bae Kim, et al.
Pageof 51

Showing results (81-90 of 509) with videos related to

Sort By:
Pageof 51
Journal of Breast Cancer|January 16, 2016
Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative IISung-Bae Kim, Yau Tsz Kok, Tran Van Thuan, et al.
Human Pathology|August 30, 2006
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypesMi-Jung Kim, Jae Y Ro, Sei-Hyun Ahn, et al.
The Laryngoscope|February 19, 2013
Clinical characteristics and prognostic factors of adenoid cystic carcinoma of the head and neckYunsuk Choi, Sung-Bae Kim, Dok Hyun Yoon, et al.
Cancer Research and Treatment|June 27, 2021
Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerHyehyun Jeong, Jae Ho Jeong, Jeong Eun Kim, et al.
Future Oncology (London, England)|August 22, 2019
Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from AsiaBinghe Xu, Sung-Bae Kim, Kenichi Inoue, et al.
Cancer Research and Treatment|March 30, 2021
Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA TrialKyung-Hun Lee, Joohyuk Sohn, Annabel Goodwin, et al.
Journal of Korean Medical Science|June 18, 2004
Alternative therapy and abnormal liver function during adjuvant chemotherapy in breast cancer patientsJin-Hee Ahn, Sung-Bae Kim, Mi Ra Yun, et al.
The Laryngoscope|June 1, 2017
Pretreatment albumin level predicts survival in head and neck squamous cell carcinomaWon Sub Lim, Jong-Lyel Roh, Sung-Bae Kim, et al.
International Journal of Clinical Oncology|July 21, 2017
Aspirin use and head and neck cancer survival: an observational study of 11,623 person-years follow-upShin-Ae Kim, Jong-Lyel Roh, Sung-Bae Kim, et al.
Medicine|May 14, 2016
Noncancer-Related Health Events and Mortality in Head and Neck Cancer Patients After Definitive Radiotherapy: A Prospective StudyHo-Seob Kang, Jong-Lyel Roh, Sung-Bae Kim, et al.
Pageof 51